Can blood markers reveal recovery after cardiac arrest?

NCT ID NCT06587763

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study looks at blood samples from adults who survived an out-of-hospital cardiac arrest. About six months after the event, researchers collect a small blood sample to measure various biomarkers. The goal is to see if these markers relate to how well survivors recover, including their daily functioning and thinking abilities. By analyzing these samples, the study aims to uncover clues that might improve future care and support for cardiac arrest survivors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help identify biological markers that predict long-term recovery and guide follow-up care for cardiac arrest survivors.
What could go wrong
This is an observational study with no intervention, so it cannot prove cause and effect. Results depend on the number of participants and may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Dec 2032

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients with an out-of-hospital cardiac arrest who survived to six months follow-up

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Survivors of out-of-cardiac arrest who participate in the extended follow-up study of the STEPCARE trial at selected sites only Exclusion Criteria: * Patients not participating in the extended follow-up at participating sites

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac arrest, out-of-hospital are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain injury cardiac arrest dementia Inflammation Out-of-Hospital Cardiac Arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Helsingborgs Hospital

    Helsingborg, Sweden

  • Skåne University Hospital

    Malmö, Sweden

  • Skåne university hospital

    Lund, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.